PMID- 8016589
OWN - NLM
STAT- MEDLINE
DCOM- 19940725
LR  - 20190909
IS  - 0300-9742 (Print)
IS  - 0300-9742 (Linking)
VI  - 23
IP  - 3
DP  - 1994
TI  - A human T-cell lymphotropic virus type I carrier with temporal arteritis 
      terminating in acute myelogenous leukemia.
PG  - 151-3
AB  - A human T-cell lymphotropic virus type I (HTLV-I) carrier with temporal arteritis 
      (TA) in whom acute myelogenous leukemia (AML) developed 1 year after successful 
      treatment of the autoimmune disease is described. This case suggested that the 
      induction of immunodeficiency by infection with HTLV-I may be related to the 
      development of the autoimmune disease and malignancy.
FAU - Shimamoto, Y
AU  - Shimamoto Y
AD  - Department of Internal Medicine, Saga Medical School, Japan.
FAU - Matsunaga, C
AU  - Matsunaga C
FAU - Suga, K
AU  - Suga K
FAU - Fukushima, N
AU  - Fukushima N
FAU - Nomura, K
AU  - Nomura K
FAU - Yamaguchi, M
AU  - Yamaguchi M
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - England
TA  - Scand J Rheumatol
JT  - Scandinavian journal of rheumatology
JID - 0321213
RN  - 9PHQ9Y1OLM (Prednisolone)
SB  - IM
MH  - Aged
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - *Carrier State
MH  - Female
MH  - Giant Cell Arteritis/drug therapy/*microbiology
MH  - HTLV-I Infections/*complications
MH  - Humans
MH  - Leukemia, Myeloid, Acute/drug therapy/*etiology
MH  - Prednisolone/therapeutic use
EDAT- 1994/01/01 00:00
MHDA- 1994/01/01 00:01
CRDT- 1994/01/01 00:00
PHST- 1994/01/01 00:00 [pubmed]
PHST- 1994/01/01 00:01 [medline]
PHST- 1994/01/01 00:00 [entrez]
AID - 10.3109/03009749409103050 [doi]
PST - ppublish
SO  - Scand J Rheumatol. 1994;23(3):151-3. doi: 10.3109/03009749409103050.